Scopolamine

CHEMBL569713 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

303.4 g/mol

LogP

0.9

Phase

4

Available as a skin patch worn behind the ear, this medication prevents the nausea and vomiting associated with motion sickness or post-surgical recovery by blocking nerve signals in the brain's balance and nausea centers. It is also occasionally used to reduce certain secretions in palliative care and respiratory conditions.

Moleküler Ağırlık

303,3500 g/mol

LogP

0,90

TPSA

62,30 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Ovarian Cancer Bladder Cancer Glaucoma Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Epilepsy Bipolar Disorder Generalized Anxiety Disorder Obesity Major Depressive Disorder Breast Cancer Chronic Pain Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12

InChI

InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1

Molecular Formula

C17H21NO4

HBD / HBA

1 / 5

Döndürülebilir Bağlar

5

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Available as a skin patch worn behind the ear, this medication prevents the nausea and vomiting associated with motion sickness or post-surgical recovery by blocking nerve signals in the brain's balance and nausea centers. It is also occasionally used to reduce certain secretions in palliative care and respiratory conditions.

Yes, Scopolamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL569713. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3000322. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Scopolamine PillFYI'da

Yapı

Hızlı Veriler

Formül: C17H21NO4
Eş Anlamlılar: 7

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.